Squarepoint’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-67,271
Closed -$654K 4840
2025
Q4
$654K Sell
67,271
-4,536
-6% -$38.6K ﹤0.01% 2986
2025
Q3
$301K Buy
71,807
+3,878
+6% +$24.8K ﹤0.01% 3666
2025
Q2
$631K Buy
67,929
+54,178
+394% +$473K ﹤0.01% 3072
2025
Q1
$134K Sell
13,751
-4,731
-26% -$58.5K ﹤0.01% 4136
2024
Q4
$224K Sell
18,482
-1,082
-6% -$13.1K ﹤0.01% 4384
2024
Q3
$214K Buy
+19,564
New +$199K ﹤0.01% 3644
2024
Q1
Sell
-17,716
Closed -$149K 4508
2023
Q4
$149K Buy
+17,716
New +$205K ﹤0.01% 3679
2023
Q3
Sell
-18,607
Closed -$432K 4161
2023
Q2
$432K Sell
18,607
-53,706
-74% -$1.05M ﹤0.01% 2717
2023
Q1
$1.28M Sell
72,313
-4,647
-6% -$111K 0.01% 1726
2022
Q4
$2.09M Buy
+76,960
New +$1.6M 0.01% 1340
2022
Q3
Sell
-31,434
Closed -$549K 3357
2022
Q2
$549K Sell
31,434
-11,676
-27% -$192K ﹤0.01% 1961
2022
Q1
$732K Buy
+43,110
New +$813K ﹤0.01% 1782
2021
Q3
Sell
-38,421
Closed -$1.48M 3345
2021
Q2
$1.48M Buy
38,421
+2,969
+8% +$102K 0.01% 1363
2021
Q1
$1.08M Sell
35,452
-35,070
-50% -$1.31M 0.01% 1445
2020
Q4
$2.69M Buy
70,522
+39,591
+128% +$1.65M 0.02% 784
2020
Q3
$712K Buy
30,931
+7,568
+32% +$172K 0.01% 1196
2020
Q2
$581K Sell
23,363
-31,762
-58% -$562K 0.01% 1232
2020
Q1
$550K Sell
55,125
-33,458
-38% -$499K 0.01% 987
2019
Q4
$1.27M Buy
88,583
+66,784
+306% +$962K 0.01% 1191
2019
Q3
$303K Buy
21,799
+5,599
+35% +$68.7K ﹤0.01% 1898
2019
Q2
$237K Buy
+16,200
New +$234K ﹤0.01% 2039

Other funds holding REPL

Squarepoint's REPL Position: Q1 2026 in Review

Squarepoint sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 67,271 shares — an estimated $654K sold.

Squarepoint first reported a position in REPL in Q2 2019 and held it in 21 quarters. The position peaked at $2.69M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Squarepoint reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 67,271 Replimune Group shares in Q1 2026, an estimated $654K.
  • Squarepoint first reported a position in Replimune Group in Q2 2019 and held it in 21 quarters.
  • Squarepoint's Replimune Group position peaked at $2.69M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.